— Quest Diagnostics (NYSE: DGX) reported third quarter 2019 adjusted EPS of $1.76 vs. $1.71 expected.
Check below Quest Diagnostics Q3 2019 earnings infograph
— GAAP EPS of continuing operations increased 2.8% year-over-year to $1.56.
— Revenue grew 3.5% to $1.96 billion vs. $1.94 billion expected.
— Diagnostic Information Services revenue grew 3.7% to $1.88 billion.
— For fiscal 2019, revenue is expected to be approximately $7.72 billion.
— FY19 adjusted EPS is pegged to be between $6.45 and $6.50. Reported EPS from continuing operations is touted to be $5.48-5.43.
— DGX stock, which reached its 52-week high on Sept. 20, inched down 0.37% to $102.28 yesterday.
Tyson Foods Inc. (NYSE: TSN) reported first quarter 2023 earnings results today. Sales rose 2.5% year-over-year to $13.2 billion. Net income attributable to Tyson was $316 million, or $0.88 per
Apple Inc. (NASDAQ: AAPL) this week reported its first revenue decline in more than three years, even as the high inflation continues to squeeze customers’ spending power. Sales of the
Chipmaker Qualcomm, Inc. (NASDAQ: QCOM) has reported lower earnings and revenues for the first quarter of 2023. The company also provided guidance for the second quarter of 2023. At $9.5